Studies have revealed that KPNA2 is abnormally expressed and as a poor prognosis predictor for multiple malignancies, including hepatocellular, bladder and breast carcinoma, and malignant melanoma [9, 16, 17, 30]. The gene discussed is KPNA2; the disease is melanoma.